126 related articles for article (PubMed ID: 19775624)
1. Multiple endocrine neoplasia type 2 (MEN 2).
Frank-Raue K; Raue F
Eur J Cancer; 2009 Sep; 45 Suppl 1():267-73. PubMed ID: 19775624
[No Abstract] [Full Text] [Related]
2. [Multiple endocrine neoplasia type IIa (MEN2A)].
Hashizume K; Suzuki S; Shigematsu S; Takeda T
Nihon Rinsho; 2006 Sep; Suppl 3():337-42. PubMed ID: 17022559
[No Abstract] [Full Text] [Related]
3. Multiple endocrine neoplasia type 2: clinical aspects.
Gimm O
Front Horm Res; 2001; 28():103-30. PubMed ID: 11443849
[No Abstract] [Full Text] [Related]
4. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
5. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Machens A; Dralle H
Surgery; 2008 May; 143(5):696; author reply 697. PubMed ID: 18436021
[No Abstract] [Full Text] [Related]
7. Multiple endocrine neoplasia type 2: clinical manifestations and management.
Traugott AL; Moley JF
Cancer Treat Res; 2010; 153():321-37. PubMed ID: 19957233
[No Abstract] [Full Text] [Related]
8. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
[TBL] [Abstract][Full Text] [Related]
9. [Multiple endocrine neoplasia syndrome].
Shchepotin IB; Zotov AS
Vopr Onkol; 2005; 51(6):722-7. PubMed ID: 17037044
[No Abstract] [Full Text] [Related]
10. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside.
Machens A; Dralle H
Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
12. Molecular implications of RET mutations for pheochromocytoma risk in multiple endocrine neoplasia 2.
Gujral TS; Mulligan LM
Ann N Y Acad Sci; 2006 Aug; 1073():234-40. PubMed ID: 17102091
[TBL] [Abstract][Full Text] [Related]
13. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract][Full Text] [Related]
14. The RET Protooncogene.
Traugott AL; Moley JF
Cancer Treat Res; 2010; 153():303-19. PubMed ID: 19957232
[No Abstract] [Full Text] [Related]
15. Pheochromocytoma penetrance varies by RET mutation in MEN 2A.
Quayle FJ; Fialkowski EA; Benveniste R; Moley JF
Surgery; 2007 Dec; 142(6):800-5; discussion 805.e1. PubMed ID: 18063059
[TBL] [Abstract][Full Text] [Related]
16. Extrathyroidal manifestations of multiple endocrine neoplasia type 2.
Brauckhoff M; Gimm O
Thyroid; 2009 Jun; 19(6):555-7. PubMed ID: 19499988
[No Abstract] [Full Text] [Related]
17. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
Ospina NS; Maraka S; Donegan D; Morris JC
Thyroid; 2017 Oct; 27(10):1332-1334. PubMed ID: 28747092
[TBL] [Abstract][Full Text] [Related]
18. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family].
Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L
Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576
[TBL] [Abstract][Full Text] [Related]
19. [Multiple endocrine neoplasia type 2a and 2b].
Vestergaard P
Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
[TBL] [Abstract][Full Text] [Related]
20. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
